GVHD Experimental Platform of InnoModels Biotechnology: A New Era of Immune Disease Research
- Categories:Company news
- Author:InnoModels Biotechnology
- Origin:InnoModels Biotechnology
- Time of issue:2024-01-03 16:25
- Views:
(Summary description)In the field of biomedicine, the GVHD experimental platform is an important innovation of InnoModels Biotechnology. With its unique advantages, the platform provides a new solution for immune disease research. In this article, we will introduce the various aspects of the GVHD platform to give readers an in-depth understanding of its excellent performance and prospects for wide application.
GVHD Experimental Platform of InnoModels Biotechnology: A New Era of Immune Disease Research
(Summary description)In the field of biomedicine, the GVHD experimental platform is an important innovation of InnoModels Biotechnology. With its unique advantages, the platform provides a new solution for immune disease research. In this article, we will introduce the various aspects of the GVHD platform to give readers an in-depth understanding of its excellent performance and prospects for wide application.
- Categories:Company news
- Author:InnoModels Biotechnology
- Origin:InnoModels Biotechnology
- Time of issue:2024-01-03 16:25
- Views:
In the field of biomedicine, the GVHD experimental platform is an important innovation of InnoModels Biotechnology. With its unique advantages, the platform provides a new solution for immune disease research. In this article, we will introduce the various aspects of the GVHD platform to give readers an in-depth understanding of its excellent performance and prospects for wide application.
Introduction of GVHD platform of InnoModels Biotechnology
GVHD platform is a comprehensive experimental solution for immune disease research, aiming to provide one-stop service from cell model preparation, in vitro experiments to data analysis. Based on the advanced gene editing technology, the platform can realize in-depth research on the pathogenesis of GVHD through genetic modification of patient-derived T cells.
InnoModels Biotechnology GVHD Experiment Process
Patient-derived T-cell collection: obtain samples containing GVHD-related T-cells by collecting patient biopsy tissue or peripheral blood.
Gene modification: Using gene editing techniques such as CRISPR-Cas9, T cells are genetically modified to express specific antigen receptors or co-stimulatory molecules.
In vitro culture: the genetically modified T cells are co-cultured with model cells such as donor skin fibroblasts to simulate the environment of GVHD pathogenesis.
Observation and detection: GVHD-related signaling pathways were observed and detected by flow cytometry, fluorescence in situ hybridization and other techniques.
Data analysis: Combining experimental data and clinical information, in-depth analysis and interpretation of GVHD pathogenesis.
Advantages and features of GVHD experimental platform of InnoModels Biotechnology
Highly customized: Provide personalized gene modification solutions according to the specific conditions of different patients to ensure the accuracy and reliability of experimental results.
Efficient: One-stop service mode shortens the experimental cycle and improves research efficiency.
Innovative: Utilizing advanced gene editing technology, it provides new ideas and methods for GVHD research.
Reliable data: ensure the accuracy and reliability of experimental data through multi-dimensional and multi-level testing and analysis.
Application fields of GVHD experimental platform of InnoModels Biotechnology
The GVHD experimental platform is suitable for the research of various immune diseases, such as acute GVHD and chronic GVHD. The platform can provide clinicians, researchers and postgraduate students with comprehensive research support on the pathogenesis of GVHD, which helps to promote the diagnosis and treatment level of related diseases.
Conclusion
With its unique advantages and features, the GVHD experimental platform of InnoModels Biotechnology has opened up a new way for immune disease research. The platform not only improves research efficiency, but also provides reliable data support for clinicians and researchers. In the future, with the in-depth development of immune disease research, the application prospect of GVHD experimental platform will be even broader.
- Tel 15010000264
- After sales
- Tel 13810723384
- Top
InnoModels Biotechnology (Beijing) Co., Ltd.
TEL:15010000264 13810723384
Email:cndw@imodels.tec
Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing
Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company